Difference between revisions of "Part:BBa S04080"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_S04080 short</partinfo> | <partinfo>BBa_S04080 short</partinfo> | ||
Line 5: | Line 4: | ||
Construction intermediate | Construction intermediate | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | The phage λcam was used to establish lysogens of ''E. coli'' strain DH10B carrying rcsA induction devices in pSB1A2. Using the Caltech iGEM [http://2008.igem.org/Team:Caltech/Protocols/rcsA_Lysogen_Induction rcsA lysogen induction protocol] and then [http://2008.igem.org/Team:Caltech/Protocols/Titering titering] the resulting phage on wild-type ''E. coli'', the series of devices S04080 (no promoter), K137129 (weak RBS B0033), K137118 (medium RBS B0032), K137114 (strong RBS B0034), and K137117 (strong RBS B0034 plus constitutive cI expression) produced the following concentrations of plaque forming units (pfu/mL). | ||
+ | |||
+ | [[Image:RcsA.gif|700px]] | ||
+ | |||
+ | Increasing the RBS strength increased the background lysogen induction without changing the dynamic range (ratio of pfu/mL induced vs. uninduced). Adding constitutive cI expression increased the dynamic range roughly 3-fold, lowering background leakiness without significantly lowering the induced expression. | ||
− | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_S04080 SequenceAndFeatures</partinfo> | <partinfo>BBa_S04080 SequenceAndFeatures</partinfo> |
Revision as of 01:14, 22 October 2008
S04079:B0015
Construction intermediate
Usage and Biology
The phage λcam was used to establish lysogens of E. coli strain DH10B carrying rcsA induction devices in pSB1A2. Using the Caltech iGEM [http://2008.igem.org/Team:Caltech/Protocols/rcsA_Lysogen_Induction rcsA lysogen induction protocol] and then [http://2008.igem.org/Team:Caltech/Protocols/Titering titering] the resulting phage on wild-type E. coli, the series of devices S04080 (no promoter), K137129 (weak RBS B0033), K137118 (medium RBS B0032), K137114 (strong RBS B0034), and K137117 (strong RBS B0034 plus constitutive cI expression) produced the following concentrations of plaque forming units (pfu/mL).
Increasing the RBS strength increased the background lysogen induction without changing the dynamic range (ratio of pfu/mL induced vs. uninduced). Adding constitutive cI expression increased the dynamic range roughly 3-fold, lowering background leakiness without significantly lowering the induced expression.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]